Surgeons at Western Pennsylvania Hospital report that laparoscopic surgery for obesity, known as Roux-en-Y gastric bypass, effectively improves unhealthy conditions associated with severe clinical obesity (or "morbid" obesity). The results, which were presented at the 69th Annual Scientific Meeting of the American College of Gastroenterology, reveal that after this surgery many patients are able to stop medications for a range of serious obesity-related health problems, including diabetes, sleep apnea, asthma, and high blood pressure.
"Comorbities associated with morbid obesity decrease life expectancy and impair quality of life," notes Pavlos Papasavas, M.D., one of the researchers at Western Pennsylvania Hospital. He and his colleagues followed 455 patients and collected data on medications used to treat comorbid diseases.
At follow-up, almost half (48.7 percent) of patients who took medications for high blood pressure preoperatively were now off medications. In addition, 92 percent of postoperative gastric bypass patients who took both oral medications for diabetes and insulin were off these medications at the time of their last follow-up. Another area of improvement was degenerative joint disease, with 32.5 percent of patients taking medications for this condition preoperatively, of whom 60 percent were off medications at follow-up. (Please see the attached abstract for a table summarizing all the findings.)
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News